Effect of sequence variants on variance in glucose levels predicts type 2 diabetes risk and accounts for heritability.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsIvarsdottir, Erna V
Daneshpour, Maryam S
Hreidarsson, Astradur B
Thorsson, Arni V
Gudbjartsson, Daniel F
MetadataShow full item record
CitationEffect of sequence variants on variance in glucose levels predicts type 2 diabetes risk and accounts for heritability. 2017, 49 (9):1398-1402 Nat. Genet.
AbstractSequence variants that affect mean fasting glucose levels do not necessarily affect risk for type 2 diabetes (T2D). We assessed the effects of 36 reported glucose-associated sequence variants on between- and within-subject variance in fasting glucose levels in 69,142 Icelanders. The variant in TCF7L2 that increases fasting glucose levels increases between-subject variance (5.7% per allele, P = 4.2 × 10(-10)), whereas variants in GCK and G6PC2 that increase fasting glucose levels decrease between-subject variance (7.5% per allele, P = 4.9 × 10(-11) and 7.3% per allele, P = 7.5 × 10(-18), respectively). Variants that increase mean and between-subject variance in fasting glucose levels tend to increase T2D risk, whereas those that increase the mean but reduce variance do not (r(2) = 0.61). The variants that increase between-subject variance increase fasting glucose heritability estimates. Intuitively, our results show that increasing the mean and variance of glucose levels is more likely to cause pathologically high glucose levels than increase in the mean offset by a decrease in variance.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
RightsArchived with thanks to Nature genetics
- Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk.
- Authors: Reiling E, van 't Riet E, Groenewoud MJ, Welschen LM, van Hove EC, Nijpels G, Maassen JA, Dekker JM, 't Hart LM
- Issue date: 2009 Sep
- Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes.
- Authors: Shi Y, Li Y, Wang J, Wang C, Fan J, Zhao J, Yin L, Liu X, Zhang D, Li L
- Issue date: 2017
- Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
- Authors: Tam CH, Ho JS, Wang Y, Lee HM, Lam VK, Germer S, Martin M, So WY, Ma RC, Chan JC, Ng MC
- Issue date: 2010 Jul 8
- Common genetic determinants of glucose homeostasis in healthy children: the European Youth Heart Study.
- Authors: Kelliny C, Ekelund U, Andersen LB, Brage S, Loos RJ, Wareham NJ, Langenberg C
- Issue date: 2009 Dec
- HbA1c-based diabetes diagnosis among patients with glucokinase mutation (GCK-MODY) is affected by a genetic variant of glucose-6-phosphatase (G6PC2).
- Authors: Borowiec M, Fendler W, Dusatkova P, Antosik K, Pruhova S, Cinek O, Mysliwiec M, Jarosz-Chobot P, Malecki MT, Mlynarski W
- Issue date: 2012 Nov